MD profile · all as-reported value updates
Pediatrix Medical Group, Inc. (MD) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating income | 2019 | -1,136,049,000 | 171,756,000 | 1,307,805,000 | +115.12% | revised comparative figure | 0001193125-20-042622 0000950170-22-001387 | 3 filed observations examined for this concept and period. |
| Revenue | 2018 | 3,647,123,000 | 1,723,107,000 | -1,924,016,000 | -52.75% | revised comparative figure | 0001193125-19-040891 0001193125-21-047064 | 3 filed observations examined for this concept and period. |
| Revenue | 2019 | 3,513,542,000 | 1,779,759,000 | -1,733,783,000 | -49.35% | revised comparative figure | 0001193125-20-042622 0000950170-22-001387 | 3 filed observations examined for this concept and period. |
| Operating income | 2018 | 445,848,000 | 248,388,000 | -197,460,000 | -44.29% | revised comparative figure | 0001193125-19-040891 0001193125-21-047064 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2017 | 60,200,000 | 40,445,000 | -19,755,000 | -32.82% | revised comparative figure | 0001193125-18-045748 0001193125-21-047064 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2018 | 36,745,000 | 40,774,000 | 4,029,000 | +9.88% | revised comparative figure | 0001193125-19-040891 0000950170-22-001387 | 4 filed observations examined for this concept and period. |
| Operating cash flow | 2018 | 289,925,000 | 313,708,000 | 23,783,000 | +7.58% | revised comparative figure | 0001193125-19-040891 0001193125-21-047064 | 3 filed observations examined for this concept and period. |
| Revenue | 2017 | 3,458,312,000 | 3,253,391,000 | -204,921,000 | -5.93% | revised comparative figure | 0001193125-19-040891 0001193125-20-042622 | 2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing. |
| Operating income | 2017 | 480,076,000 | 454,892,000 | -25,184,000 | -5.25% | revised comparative figure | 0001193125-18-045748 0001193125-20-042622 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2019 | 112,767,000 | 107,870,000 | -4,897,000 | -4.34% | revised comparative figure | 0001193125-20-042622 0000950170-23-003127 | 4 filed observations examined for this concept and period. |
| Operating cash flow | 2019 | 346,637,000 | 357,711,000 | 11,074,000 | +3.10% | revised comparative figure | 0001193125-20-042622 0000950170-22-001387 | 3 filed observations examined for this concept and period. |